European Companies Search Engine
MD: F. K., U. W. · Profit Transfer: Dr. Kade Pharmazeutische Fabrik GmbH · Change of headquarters: DR. KADE avenda GmbH · Address · Capital: €25,000 · Shareholder agreement · Seat: Berlin … Hrb 13 Jun 2017 German Trade Register Announcements, Germany (29/05/2017)
Overview
Text
HRB 187106 B: DR. KADE avenda GmbH,
Unnamed street ??, 12277 Berlin, Germany
. Company: DR. KADE avenda GmbH; Seat/; Branch: Berlin; Business address:
Unnamed street ??, 12277 Berlin, Germany
; The object: the commercial agent's business, in particular for pharmaceuticals, medical devices and other pharmacy products for personal and third-party account to pharmacists and the pharmaceutical wholesalers at home and abroad; Measures of promotion on behalf of third parties, in particular against pharmacists and pharmaceutical wholesalers at home and abroad. Share capital: EUR 25,000.00; Representation regulation: If a managing director is appointed, he shall represent the company alone. If several directors have been appointed, the company is represented jointly by two directors or by a managing director in community with one authorized representative. The power of sole representation may be granted. Managing Directors: 1. König, Felix, *??.??.????, Berlin; with the power to represent the company alone; Managing Directors: 2. Wynands, Ute Kristina, *??.??.????, Berlin; with the power to represent the company alone; Legal form: Limited Liability Company; Partnership agreement of: January 20, 2012 last amended by resolution of February 6, 2012. By resolution of the shareholders' meeting of May 12, 2017, the registered office of the company has been moved from Konstanz (Amtsgericht Freiburg HRB 707962) to Berlin and the partnership agreement has been amended in Section 1 (headquarters). Legal agreement: On February 15, 2012, a profit transfer agreement was concluded with the "Dr. Kade Pharmazeutische Fabrik GmbH", Berlin (Amtsgericht Charlottenburg (Berlin) HRB 8629 B), which was approved by the Shareholders' Meeting on February 27, 2012. The contract concluded was amended on February 15, 2012. The shareholders' meeting approved the change on the same day. Note: Date of first registration: January 23, 2012
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: DR. KADE avenda GmbH, Berlin, Germany.